|
1
|
Krejs GJ: Gastric cancer: Epidemiology and
risk factors. Dig Dis. 28:600–603. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yasui W, Sentani K, Sakamoto N, Anami K,
Naito Y and Oue N: Molecular pathology of gastric cancer: Research
and practice. Pathol Res Pract. 207:608–612. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Karlsson R, Pedersen ED, Wang Z and
Brakebusch C: Rho GTPase function in tumorigenesis. Biochim Biophys
Acta. 1796:91–98. 2009.PubMed/NCBI
|
|
4
|
Van der Meel R, Symons MH, Kudernatsch R,
Kok RJ, Schiffelers RM, Storm G, Gallagher WM and Byrne AT: The
VEGF/Rho GTPase signalling pathway: A promising target for
anti-angiogenic/anti-invasion therapy. Drug Discov Today.
16:219–228. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sinha S and Yang W: Cellular signaling for
activation of Rho GTPase Cdc42. Cell Signal. 20:1927–1934. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Stengel K and Zheng Y: Cdc42 in oncogenic
transformation, invasion, and tumorigenesis. Cell Signal.
23:1415–1423. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
de Toledo M, Anguille C, Roger L, Roux P
and Gadea G: Cooperative anti-invasive effect of Cdc42/Rac1
activation and ROCK inhibition in SW620 colorectal cancer cells
with elevated blebbing activity. PLoS One. 7:e483442012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zuo Y, Wu Y and Chakraborty C: Cdc42
negatively regulates intrinsic migration of highly aggressive
breast cancer cells. J Cell Physiol. 227:1399–1407. 2012.
View Article : Google Scholar
|
|
9
|
Lee YC, Cheng TH, Lee JS, Chen JH, Liao
YC, Fong Y, Wu CH and Shih YW: Nobiletin, a citrus flavonoid,
suppresses invasion and migration involving FAK/PI3K/Akt and small
GTPase signals in human gastric adenocarcinoma AGS cells. Mol Cell
Biochem. 347:103–115. 2011. View Article : Google Scholar
|
|
10
|
Chen Q, Chen X, Zhang M, Fan Q, Luo S and
Cao X: miR-137 is frequently down-regulated in gastric cancer and
is a negative regulator of Cdc42. Dig Dis Sci. 56:2009–2016. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen QY, Jiao DM, Yao QH, Yan J, Song J,
Chen FY, Lu GH and Zhou JY: Expression analysis of Cdc42 in lung
cancer and modulation of its expression by curcumin in lung cancer
cell lines. Int J Oncol. 40:1561–1568. 2012.PubMed/NCBI
|
|
12
|
Zhang JY, Zhang D and Wang EH:
Overexpression of small GTPases directly correlates with expression
of δ-catenin and their coexpression predicts a poor clinical
outcome in nonsmall cell lung cancer. Mol Carcinog. 52:338–347.
2013. View
Article : Google Scholar
|
|
13
|
Liu Y, Xu H, Liu N, Wang L and Wang E:
Correlation of expression of p120ctn, RhoA, and Cdc42 and their
significance in non-small cell lung cancer. Zhongguo Fei Ai Za Zhi.
8:304–308. 2005.In Chinese. PubMed/NCBI
|
|
14
|
Jiang LC, Zhang Y and Qu XC: Effects of
Cdc42 overexpression on the estrogen-enhanced multidrug resistance
in breast cancer cells. Zhonghua Zhong Liu Za Zhi. 33:489–493.
2011.In Chinese. PubMed/NCBI
|
|
15
|
Kamai T, Yamanishi T, Shirataki H, Takagi
K, Asami H, Ito Y and Yoshida K: Overexpression of RhoA, Rac1, and
Cdc42 GTPases is associated with progression in testicular cancer.
Clin Cancer Res. 10:4799–4805. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gómez Del Pulgar T, Valdés-Mora F, Bandrés
E, Pérez-Palacios R, Espina C, Cejas P, García-Cabezas MA, Nistal
M, Casado E, González-Barón M, et al: Cdc42 is highly expressed in
colorectal adenocarcinoma and downregulates ID4 through an
epigenetic mechanism. Int J Oncol. 33:185–193. 2008.PubMed/NCBI
|
|
17
|
Liu Z, Feng JG, Tuersun A, Liu T, Liu H,
Liu Q, Zheng ST, Huang CG, Lv GD, Sheyhidin I and Lu XM: Proteomic
identification of differentially-expressed proteins in esophageal
cancer in three ethnic groups in Xinjiang. Mol Biol Rep.
38:3261–3269. 2011. View Article : Google Scholar
|
|
18
|
Strzalka W and Ziemienowicz A:
Proliferating cell nuclear antigen (PCNA): A key factor in DNA
replication and cell cycle regulation. Ann Bot. 107:1127–1140.
2011. View Article : Google Scholar :
|
|
19
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bauvois B: New facets of matrix
metalloproteinases MMP-2 and MMP-9 as cell surface transducers:
Outside-in signaling and relationship to tumor progression. Biochim
Biophys Acta. 1825:29–36. 2012.
|
|
21
|
Yang S, Zhao Z, Wu R, Lu H, Zhang X, Huan
C, Wang C, Wu X and Guan G: Expression and biological relationship
of vascular endothelial growth factor-A and matrix
metalloproteinase-9 in gastric carcinoma. J Int Med Res.
39:2076–2085. 2011. View Article : Google Scholar
|
